Nonsynonymous Mutations in Linker-2 of the Pdr5 Multidrug Transporter Identify a New RNA Stability Element.


Journal

G3 (Bethesda, Md.)
ISSN: 2160-1836
Titre abrégé: G3 (Bethesda)
Pays: England
ID NLM: 101566598

Informations de publication

Date de publication:
07 01 2020
Historique:
pubmed: 24 11 2019
medline: 9 6 2020
entrez: 24 11 2019
Statut: epublish

Résumé

Analysis of synonymous mutations established that although the primary amino acid sequence remains unchanged, alterations in transcription and translation can result in significant phenotypic consequences. We report the novel observation that a series of nonsynonymous mutations in an unconserved stretch of amino acids found in the yeast multidrug efflux pump Pdr5 increases expression, thus enhancing multidrug resistance. Cycloheximide chase experiments ruled out the possibility that the increased steady-state level of Pdr5 was caused by increased protein stability. Quantitative-RT PCR experiments demonstrated that the mutants had levels of

Identifiants

pubmed: 31757931
pii: g3.119.400863
doi: 10.1534/g3.119.400863
pmc: PMC6945031
doi:

Substances chimiques

ATP-Binding Cassette Transporters 0
PDR5 protein, S cerevisiae 0
Saccharomyces cerevisiae Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

357-369

Subventions

Organisme : NIGMS NIH HHS
ID : R15 GM077211
Pays : United States

Informations de copyright

Copyright © 2020 Rahman et al.

Références

Antimicrob Agents Chemother. 2018 Dec 21;63(1):
pubmed: 30348662
Biochim Biophys Acta. 2013 Feb;1828(2):479-90
pubmed: 23122779
J Biol Chem. 1996 Dec 6;271(49):31543-8
pubmed: 8940170
BMC Mol Biol. 2009 Oct 30;10:99
pubmed: 19874630
Nat Rev Cancer. 2002 Jan;2(1):48-58
pubmed: 11902585
Cell. 2014 Feb 13;156(4):812-24
pubmed: 24529382
Biochemistry. 2010 Jun 1;49(21):4440-9
pubmed: 20426485
J Biol Chem. 2013 Oct 18;288(42):30420-31
pubmed: 24019526
Genome Biol. 2005;6(10):R86
pubmed: 16207357
Elife. 2018 Sep 07;7:
pubmed: 30192227
Science. 2007 Jan 26;315(5811):525-8
pubmed: 17185560
Science. 2009 Sep 25;325(5948):1682-6
pubmed: 19779198
Anal Chem. 2002 Oct 15;74(20):5383-92
pubmed: 12403597
J Proteome Res. 2007 Mar;6(3):1190-7
pubmed: 17330950
Trends Genet. 2014 Jul;30(7):308-21
pubmed: 24954581
J Biol Chem. 1996 Jan 19;271(3):1708-16
pubmed: 8576173
Genome Biol. 2005;6(9):R75
pubmed: 16168082
J Struct Biol. 2011 Feb;173(2):333-44
pubmed: 21034832
Physiol Rev. 1999 Jan;79(1 Suppl):S77-S107
pubmed: 9922377
Biochem Soc Trans. 2018 Aug 20;46(4):937-944
pubmed: 30065107
Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2193-8
pubmed: 17287358
Nat Commun. 2014 Jun 10;5:4076
pubmed: 24912567
Antimicrob Agents Chemother. 2013 Feb;57(2):1025-34
pubmed: 23254431
J Biol Chem. 1999 Dec 24;274(52):37139-46
pubmed: 10601275
FEMS Yeast Res. 2018 Jun 1;18(4):
pubmed: 29668941
Nucleic Acids Res. 2003 Jul 1;31(13):3406-15
pubmed: 12824337
Mol Cell Proteomics. 2008 Jul;7(7):1389-96
pubmed: 18407956
Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5069-74
pubmed: 18356296
Biochem J. 2015 May 1;467(3):353-63
pubmed: 25886173
J Biol Chem. 2008 Dec 12;283(50):35010-22
pubmed: 18842589
Mol Microbiol. 2019 Oct;112(4):1131-1144
pubmed: 31294884
Hum Mol Genet. 2003 Feb 1;12(3):205-16
pubmed: 12554675
Blood. 2011 May 19;117(20):5362-71
pubmed: 21421839
Pigment Cell Melanoma Res. 2015 Nov;28(6):673-84
pubmed: 26300548
Antimicrob Agents Chemother. 2008 Apr;52(4):1481-92
pubmed: 18268086
Mol Cell Biol. 1995 Nov;15(11):5879-87
pubmed: 7565740
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Anal Chem. 2003 Sep 1;75(17):4646-58
pubmed: 14632076
Drug Resist Updat. 2015 Jan;18:1-17
pubmed: 25554624
Am J Med. 2012 Jan;125(1 Suppl):S3-13
pubmed: 22196207
Eukaryot Cell. 2015 Dec;14(12):1154-64
pubmed: 26407965
Biochemistry. 2007 Nov 13;46(45):13109-19
pubmed: 17956128
Cancer Res. 2014 Jan 15;74(2):598-608
pubmed: 24305879
EMBO J. 2006 Oct 18;25(20):4728-39
pubmed: 17036051
J Biol Chem. 2007 Feb 16;282(7):5063-74
pubmed: 17158869
Hum Mutat. 2002 Aug;20(2):151
pubmed: 12124998
Proc Natl Acad Sci U S A. 2005 May 3;102(18):6368-72
pubmed: 15840711

Auteurs

Hadiar Rahman (H)

Department of Biology, Catholic University of America, Washington, DC 20064.

Andrew Rudrow (A)

Department of Biology, Catholic University of America, Washington, DC 20064.

Joshua Carneglia (J)

Department of Biology, Catholic University of America, Washington, DC 20064.

Sister Stephen Patrick Joly (SSP)

Department of Biology, Catholic University of America, Washington, DC 20064.

Dante Nicotera (D)

Department of Biology, Catholic University of America, Washington, DC 20064.

Michael Naldrett (M)

Center for Biotechnology, University of Nebraska, Lincoln 68588, and.

John Choy (J)

Department of Biology, Catholic University of America, Washington, DC 20064.

Suresh V Ambudkar (SV)

Laboratory of Cell Biology, Center for Cancer Research, NCI, NIH, Bethesda, MD 20892.

John Golin (J)

Department of Biology, Catholic University of America, Washington, DC 20064, golin@cua.edu.

Articles similaires

T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis

Prevalence and implications of fragile X premutation screening in Thailand.

Areerat Hnoonual, Sunita Kaewfai, Chanin Limwongse et al.
1.00
Humans Fragile X Mental Retardation Protein Thailand Male Female
Humans Receptors, Antigen, T-Cell Proto-Oncogene Proteins p21(ras) Pancreatic Neoplasms T-Lymphocytes

Classifications MeSH